The compounds clinical file for hair, in the strict sense of controlled human efficacy trials, is close to empty
Although NDDs have been studied for many years, its pathogenesis is still not fully elucidated due to the complexity of pathogenic factors
A 2mL vial does not truly provide 20 full doses at 10 units each because 0.1mL of dead volume means you lose one dose worth of medication
The shelf life here depends on the compounding pharmacy , the specific formulation, whether it contains preservatives, and the USP chapter under which it was prepared
If your dose volume is over 1mL, consider splitting the injection into two sites
Providers need reliable sourcing, pharmacy coordination, clear clinical guidance, and confidence in when newer compounds actually make sense for the patient sitting in front of them